ロード中...
Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
The prospective identification and therapeutic targeting of oncogenic tyrosine kinases with tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of patients with non-small cell lung cancer (NSCLC). TKI therapy frequently induces dramatic clinical responses in molecularly defined cohort...
保存先:
| 出版年: | Am Soc Clin Oncol Educ Book |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734636/ https://ncbi.nlm.nih.gov/pubmed/25993168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14694/EdBook_AM.2015.35.e165 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|